TNFRSF11B and psoriasis: In our study, osteoprotegerin was not associated with CVD in patients with psoriasis, but TRANCE and TRAIL were decreased in those with CVD, and in patients without CVD and statin treatment, TRAIL was decreased in subjects with carotid artery plaques, and TRAIL and TRANCE showed no relation to CCS.